Search

everythinglearnresearchcommunity

for

Search:↓

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Customized dermatological treatments effectively address gaps in standard products, especially for complex cases.

Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.

Alopecia areata in children requires thorough diagnosis and treatment due to its impact on quality of life and link to other autoimmune diseases.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Alopecia areata causes hair loss due to immune issues, and while new treatments show promise, no universally effective solution exists yet.

Hashimoto's thyroiditis can sometimes change to Graves' disease, so patients need careful monitoring.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

The document concludes that while white skin, nail, and mucosa diseases increase skin cancer risk, they are generally harmless, especially compared to darker pigmentation conditions.

Apremilast may help treat hair loss in alopecia areata.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Gut bacteria differences may help diagnose and treat Alopecia areata.

Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Alopecia areata is hard to treat, but new targeted therapies show promise.

Vitiligo and alopecia should be covered by Medicaid and TRICARE as medical, not cosmetic, conditions.

Janus kinase inhibitors show promise for treating alopecia areata in children.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Herpes simplex virus infections should be considered in pemphigus patients to avoid unnecessary changes in treatment.

COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.